Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.

Access publication

Citation: Nash D, Srivastava A, Shen J, Penrose K, Kulkarni SG, Zimba R, You W, Berry A, Mirzayi C, Maroko A, Parcesepe AM, Grov C, Robertson MM. Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults. medRxiv [Preprint]. 2023 Oct 2:2023.09.29.23296142. doi: 10.1101/2023.09.29.23296142. PMID: 37873066; PMCID: PMC10593054.

Authors